Showing results (1171-1180 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|October 1, 1985
Pharmacokinetic evaluation of novel sustained-release dosage forms of valproic acid in humansM Bialer, M Friedman, J Dubrovsky, et al.Biopharmaceutics & Drug Disposition|January 16, 1998
Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteersJ J Zhao, J D Rogers, S D Holland, et al.Biopharmaceutics & Drug Disposition|January 16, 1998
Effects of glycosylation of hypoglycaemic drug binding to serum albuminH Koyama, N Sugioka, A Uno, et al.Biopharmaceutics & Drug Disposition|March 25, 1998
Comparative bioavailability of josamycin, a macrolide antibiotic, from a tablet and solution and the influence of dissolution on in vivo releaseM Skinner, I KanferBiopharmaceutics & Drug Disposition|March 25, 1998
Pharmacokinetics and pharmacodynamics of recombinant tissue-type plasminogen activator following intravenous administration in rabbits: a comparison of three dosing regimensS Eppler, T Senn, E Gilkerson, et al.Biopharmaceutics & Drug Disposition|April 9, 1998
No effect of chloroquine on theophylline pharmacokinetics in the ratB A Motti, M AshtonBiopharmaceutics & Drug Disposition|April 9, 1998
Pharmacokinetics of a non-narcotic analgesic, DA-5018, in ratsJ J Lee, H J Shim, S H Kim, et al.Biopharmaceutics & Drug Disposition|April 9, 1998
Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species: a comparison of mathematical modelsK R Godfrey, P Tanswell, R A Bates, et al.Biopharmaceutics & Drug Disposition|December 1, 1992
Immunosuppressive effect of cyclosporine in the hyperlipidemic rat modelD R LukeBiopharmaceutics & Drug Disposition|January 13, 2004
Disposition of WR-1065 in the liver of tumor-bearing rats following regional vs systemic administration of amifostineMicha Levi, Susan J DeRemer, Chunzhi Dou, et al.Pageof 214